TB Regimen Could Pave Way For More FDA Involvement In Neglected Tropical Diseases
TB Alliance plans to seek FDA approval for its treatment regimen, which is beginning a Phase IIb trial, as the agency looks to respond to calls for a clearer and quicker pathway for NTD drugs.
You may also be interested in...
Reagan-Udall, Still Waiting For FDA Funding, Studies Drug Toxicity Pathways
Created by Congress to help FDA modernize medical product development and evaluation, the foundation will receive its first influx of federal money to support overhead in fiscal 2012.
How Many Products Are In Development For Neglected Tropical Diseases? BVGH Takes A Closer Look
In a recent report, the nonprofit BIO Ventures for Global Health shines a light on the NTD pipelines of Big Pharma, biotechs and others.
Tropical Disease Development Partnerships Want More Help From FDA
The agency’s infrastructure is not attracting many of the Product Development Partnership sponsors, Aeras official says, but new draft guidance could help.